About Us
Innovate and forge ahead with leading original products in the industry
About Us
/
Enterprise Development
November 2022
November 2022

Approved to set up a postdoctoral scientific research workstation

August 2022
August 2022

3D FloTrix® Cell CDMO platform was officially unveiled, and the expansion of the Beijing headquarters was completed

August 2022
August 2022

Topped the list of medical enterprises with 10 times growth potential of 36 krypton

June 2022
June 2022

Listed in KPMG China's first Biotechnology Innovation 50 Enterprise List

April 2022
April 2022

Tsinghua University & Huakan Biology's original research technology won the Geneva Invention Gold Medal

March of the same year
March of the same year

3D FloTrix® Microcarriers for Vaccines Launched

March 2022
March 2022

Completed nearly 300 million yuan in round B financing, accelerating the industrialization of 3D cell "smart manufacturing"

February 2022
February 2022

Tianjin GMP production platform expanded to 4000 square meters, new 1200L microcarrier production line

July 2021
July 2021

The cumulative annual sales exceeded 10 million yuan, and the financing of nearly 100 million yuan was completed

June 2021
June 2021

The GMP manufacturing platform was successfully certified by the ISO9001 and IS013485 quality management systems

April 2021
April 2021

3D TableTrix® Cell Microcarrier Tablet obtained the qualifications DMF for pharmaceutical excipients from the US FDA (DMF:35481)

February 2021
February 2021

3D TableTrix® Cell Microcarrier Tablet obtained two qualifications for pharmaceutical excipients from CDE (Filing No.:F20200000496/F20210000003)

December 2020
December 2020

3D TableTrix® microcarrier core products were released in United States, the European Union, Japan and other countries

October 2020
October 2020

3D FIoTrix@ VS series of pilot-scale production-grade bioreactors were officially released in the market

June 2020
June 2020

Proprietary products of 3D TableTrix® series of microcarrier tablet officially were officially released in the market

January 2020
January 2020

The certification of intellectual property management system was completed

December 2019
December 2019

The application for "Zhongguancun Subversive Project" was successful; the certification of "National High-tech Enterprise" was obtained and the company ranked among top 3 in "Global Entrepreneurship World Cup" at the same time

October 2019
October 2019

followed by A GMP-certified manufacturing base of 2000 square meters launched in the next month.

March 2019
March 2019

In March 2019, Cytoniche received angel fund and a R&D center of 1500 square meters was therefore launched.

2018
2018

In 2018, the technology was successfully translated into Beijing CytoNiche Biotechnology Co., Ltd., joined by Tsinghua University equity-wise.

Copyright: Beijing CytoNiche Biotechnology Co., Ltd.
Copyright: Beijing CytoNiche Biotechnology Co., Ltd.